St. Joseph Hospital - Redwood Memorial Hospital
About Us News Room Careers Contact Us
I Want to Find Our Doctors Our Services For Patients For Visitors For Community
News Room
Dozens of St. Joseph Hospital Inpatient Rehabilitation patients gather to celebrate Christmas
St. Joseph Hospital opens new North East Wing
St. Joseph Hospital physicians treat severe wounds of shark attack victim
NECC Drug Recall
Hundreds of SJH staff complete training before the November opening of the new North East Wing
Kohl’s Department Store to donate more than $11,000 to St. Joseph Health – Humboldt County Community Resource Centers to encou
St. Joseph Hospital’s New North East Wing Set to Open
St. Joseph Hospital welcomes new intensive care unit and respiratory therapy manager
St. Joseph Hospital Welcomes New CNO
St. Joseph Hospital reaches capital campaign goal
HealthScene Community Newsletter - Spring 2012
HealthScene Community Newsletter - Winter 2012
HealthScene Community Newsletter - back issues

Article Sections

Share this page:

Google +

NECC Drug Recall

Eureka (October 25, 2012) – St. Joseph Health – Humboldt County has been notified by the Food and Drug Administration (FDA) that all medications produced by the New England Compounding Center (NECC) have been recalled as a precaution. We want to emphasize that NECC medications given to patients at our hospitals are not known to have been contaminated or to have caused infections. A very small number of our patients have received medications produced by NECC and we are notifying patients at the request of the FDA in an abundance of caution.

The reason for the recall is NECC earlier this year produced and distributed a steroid medication called methylprednisolone acetate which has resulted in an outbreak of fungal meningitis and joint infections in several states across the country. The medicine is typically given to patients who receive injections for relief of lower back pain or joint pain. While our hospital does not order this medication from NECC, we are contacting our patients who were given medications produced by NECC after May 21, 2012 just to be safe. To date, there have been no reports of infections linked to NECC products purchased and used by our hospital.

It is our goal at all times to do everything in our power to provide our patients with Perfect Care. The care and safety of our patients is our top priority. We understand that this information is alarming. We care about the health and wellness of our patients so please do not hesitate to call us if you have questions about this matter at 707-445-8121 ext. 5811.

To learn more about the investigation of products from NECC, contact the FDA's Division of Drug Information at 855-543-DRUG (3784) and press * to get the most recent information regarding the multistate meningitis outbreak, report an adverse event, or speak directly to a pharmacist. Additional information is available at and

Categories: General

Related Articles